The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of dysregulated lipid
and glucose metabolism, which is often associated with obesity, dyslipidemia and insulin …

Background Worldwide, non-alcoholic fatty liver disease (NAFLD) is a common chronic liver
disease closely associated with obesity, diabetes and other metabolic diseases. Shenling …

Mastitis, a disease that affects both dairy herds and humans, is recognized as the most
common source of losses in the dairy industry. Antibiotics have been used for years as the …

In recent years, a wealth of factors are associated with increased risk of developing non-
alcoholic fatty liver disease (NAFLD) and NAFLD is now thought to increase the risk of …

Non-alcoholic fatty liver disease (NAFLD) represents the leading cause of chronic liver
disease worldwide and the anticipated health burden is huge. There are limited therapeutic …

Sulfated polysaccharides were shown to benefit metabolic syndrome (MS) and gut
microbiota, but the contribution of sulfate group remains unclear. In this study, sulfated …

Introduction: Non-alcoholic steatohepatitis (NASH) is a chronic liver disease that can
progress to cirrhosis and hepatocellular carcinoma. Diagnosis of NASH requires a liver …

Background The biological mediators supporting the resolution of liver steatosis,
inflammation and fibrosis after bariatric surgery in patients with obesity and NAFLD remain …

Metabolic dysfunction-associated steatotic liver disease (MASLD) has garnered
considerable attention globally. Changing lifestyles, over-nutrition, and physical inactivity …